Kessler Topaz Wins Lead In Cancer Drug Stock-Drop Suit
By Alison Noon ( May 4, 2018, 8:12 PM EDT) -- Kessler Topaz Meltzer & Check LLP and its investor client on Friday secured the roles of lead counsel and plaintiff in a proposed securities class action against Tesaro Inc. blaming the pharmaceutical company for stock losses after regulators issued a national safety alert on its antiemetic cancer drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.